SAR exploration of the non-imidazole histamine H3 receptor ligand ZEL-H16 reveals potent inverse agonism

被引:0
|
作者
Wagner, Gabor [1 ]
Mocking, Tamara A. M. [1 ]
Ma, Xiaoyuan [1 ]
Slynko, Inna [1 ]
Pereira, Daniel Da Costa [1 ]
Breeuwer, Robin [1 ]
Rood, Niek J. N. [1 ]
van der Horst, Cas [1 ]
Vischer, Henry F. [1 ]
de Graaf, Chris [1 ]
de Esch, Iwan J. P. [1 ]
Wijtmans, Maikel [1 ]
Leurs, Rob [1 ]
机构
[1] Vrije Univ Amsterdam, Fac Sci, Amsterdam Inst Mol & Life Sci AIMMS, Div Med Chem, De Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands
关键词
agonism; G protein-coupled receptor (GPCR); histamine H3 receptor; inverse agonism; non-imidazole; PHARMACOLOGICAL CHARACTERIZATION; INHIBITION;
D O I
10.1002/ardp.202200451
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Histamine H-3 receptor (H3R) agonists without an imidazole moiety remain very scarce. Of these, ZEL-H16 (1) has been reported previously as a high-affinity non-imidazole H3R (partial) agonist. Our structure-activity relationship analysis using derivatives of 1 identified both basic moieties as key interaction motifs and the distance of these from the central core as a determinant for H3R affinity. However, in spite of the reported H3R (partial) agonism, in our hands, 1 acts as an inverse agonist for G alpha(i) signaling in a CRE-luciferase reporter gene assay and using an H3R conformational sensor. Inverse agonism was also observed for all of the synthesized derivatives of 1. Docking studies and molecular dynamics simulations suggest ionic interactions/hydrogen bonds to H3R residues D114(3.32) and E206(5.46) as essential interaction points.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Identification and Characterization of ZEL-H16 as a Novel Agonist of the Histamine H3 Receptor
    Shi, Ying
    Sheng, Rong
    Zhong, Tingting
    Xu, Yu
    Chen, Xiaopan
    Yang, Dong
    Sun, Yi
    Yang, Fenyan
    Hu, Yongzhou
    Zhou, Naiming
    PLOS ONE, 2012, 7 (08):
  • [2] Non-imidazole heterocyclic histamine H3 receptor antagonists
    Chai, WY
    Breitenbucher, JG
    Kwok, A
    Li, XB
    Wong, V
    Carruthers, NI
    Lovenberg, TW
    Mazur, C
    Wilson, SJ
    Axe, FU
    Jones, TK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (10) : 1767 - 1770
  • [3] Fluorinated non-imidazole histamine H3 receptor antagonists
    Isensee, K.
    Amon, M.
    Galaparti, A.
    Ligneau, X.
    Camelin, J. -C.
    Capet, M.
    Schwartz, J. -C.
    Stark, H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (08) : 2172 - 2175
  • [4] A-320436:: Potent human non-imidazole histamine H3 receptor antagonist.
    Curtis, MP
    Dwight, W
    Fox, GB
    Esbenshade, TA
    Pan, JB
    Bennani, YL
    Hancock, AA
    Faghih, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U217 - U217
  • [5] ANTICONVULSANT ACTIVITY OF NON-IMIDAZOLE HISTAMINE H3 RECEPTOR LIGANDS
    Lazewska, D.
    Schwed, J. Stephan
    Weizel, L.
    Stark, H.
    Kiec-Kononowicz, K.
    INFLAMMATION RESEARCH, 2014, 63 : S10 - S10
  • [6] Synthesis of potent non-imidazole histamine H3-receptor antagonists
    Ganellin, CR
    Leurquin, F
    Piripitsi, A
    Arrang, JM
    Garbarg, M
    Ligneau, X
    Schunack, W
    Schwartz, JC
    ARCHIV DER PHARMAZIE, 1998, 331 (12) : 395 - 404
  • [7] Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology
    T. A. Esbenshade
    B. B. Yao
    D. G. Witte
    T. L. Carr
    R. Sharma
    J. L. Baranowski
    K. M. Krueger
    T. R. Miller
    B. W. Surber
    R. Faghih
    A. A. Hancock
    Inflammation Research, 2005, 54 : S46 - S47
  • [8] Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology
    Esbenshade, TA
    Yao, BB
    Witte, DG
    Carr, TL
    Sharma, R
    Baranowski, JL
    Krueger, KM
    Miller, TR
    Surber, BW
    Faghih, R
    Hancock, AA
    INFLAMMATION RESEARCH, 2005, 54 (Suppl 1) : S46 - S47
  • [9] Piperidine variations in search for non-imidazole histamine H3 receptor ligands
    Lazewska, Dorota
    Kuder, Kamil
    Ligneau, Xavier
    Schwartz, Jean-Charles
    Schunack, Walter
    Stark, Holger
    Kiec-Kononowicz, Katarzyna
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (18) : 8729 - 8736
  • [10] The discovery of potent non-imidazole H3-receptor histamine antagonists
    Ganellin, CR
    Leurquin, F
    Piripitsi, A
    Arrang, JM
    Garbarg, M
    Ligneau, X
    Stark, H
    Schunack, W
    Schwartz, JC
    HISTAMINE RESEARCH IN THE NEW MILLENNIUM, 2001, 1224 : 25 - 31